Alnylam Pharmaceuticals, Inc.
EPS
| Fiscal Year | EPS | Cyclically Adjusted EPS |
|---|---|---|
| FY2017 | $-5.42 | $-3.79 |
| FY2018 | $-7.57 | $-4.35 |
| FY2019 | $-8.11 | $-5.18 |
| FY2020 | $-7.46 | $-5.94 |
| FY2021 | $-7.20 | $-6.58 |
EPS
| Fiscal Year | EPS | Cyclically Adjusted EPS |
|---|---|---|
| FY2017 | $-5.42 | $-3.79 |
| FY2018 | $-7.57 | $-4.35 |
| FY2019 | $-8.11 | $-5.18 |
| FY2020 | $-7.46 | $-5.94 |
| FY2021 | $-7.20 | $-6.58 |